Abstract
BACKGROUND: To study in a phase I-II trial the maximum tolerated dose, the toxicity, and the tolerance of adding radiotherapy to systemic chemotherapy administered preoperatively in patients with locoregionally advanced gastric adenocarcinoma. PATIENTS AND METHODS: Patients with adenocarcinoma of the stomach (T(3)(-)(4)N(any) or T(any)N+), performance status
| Original language | English |
|---|---|
| Pages (from-to) | 110-115 |
| Number of pages | 6 |
| Journal | Annals of Oncology |
| Volume | 14 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - 1 Jan 2003 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Neoadjuvant radiochemotherapy for locally advanced gastric cancer: a] I-II study'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver